HIV-1 envelope glycoprotein
Patent
·
OSTI ID:1376215
The present application relates to novel HIV-1 envelope glycoproteins, which may be utilized as HIV-1 vaccine immunogens, and antigens for crystallization, electron microscopy and other biophysical, biochemical and immunological studies for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions, which are formulated into the vaccines of the present invention.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-06CH11357
- Assignee:
- INTERNATIONAL AIDS VACCINE INITIATIVE
- Patent Number(s):
- 9,738,688
- Application Number:
- 14/072,209
- OSTI ID:
- 1376215
- Country of Publication:
- United States
- Language:
- English
Similar Records
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
Journal Article
·
2018
· Journal of Virology
·
OSTI ID:1626074
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Journal Article
·
2007
· Virology
·
OSTI ID:20977006
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
Journal Article
·
2019
· Nature Communications
·
OSTI ID:1624156